Suppr超能文献

基于生理活性天然产物中存在的结构基序设计与合成具有抗结核活性的新型氟代苯并咪唑类化合物

Design and Synthesis of Some Novel Fluorobenzimidazoles Substituted with Structural Motifs Present in Physiologically Active Natural Products for Antitubercular Activity.

作者信息

Nandha Bangalore, Nargund Laxmivenkatesh Gurachar, Nargund Shachindra Laxmivenkatesh, Bhat Kishore

机构信息

Department of Pharmaceutical Chemistry, Vivekananda College of Pharmacy, Rajiv Gandhi University of Health Sciences, Bangalore-560055, Karnataka, India.

Department of Pharmaceutical Chemistry, Nargund College of Pharmacy, Rajiv Gandhi University of Health Sciences, Bangalore-560085, Karnataka, India.

出版信息

Iran J Pharm Res. 2017 Summer;16(3):929-942.

Abstract

Keeping in view the drawbacks associated with research on anti-TB drugs based on plant extracts and the non-availability of fluorinated natural products with antitubercular activity has prompted us to make an effort towards the synthesis and characterization of a novel series of fifteen substituted fluorobenzimidazoles. The newly synthesized compounds were characterized by I.R, H-NMR, C-NMR, Mass, and elemental analysis. The synthesized compounds 4(a-f) and 5(b-j) have been evaluated for their - antimycobacterial activity against H37Rv strain (ATCC 27294) by MABA method. Incorporation of methylenedioxyphenyl moiety at 2- and 6-position of the benzimidazole ring furnished compounds 4d and 5i with antitubercular activity comparable or more potent than the naturally occurring compounds with reported antitubercular activity. Among the fifteen tested compounds, 4d and 5i emerged as promising hits characterized by MIC lower than that determined for sesamin against the pathogenic H37Rv strain. Antitubercular activity results indicate that these compounds may be suitable for further lead optimization. The cytotoxic effect of these active compounds on THP-1 cell line was assessed by MTT assay and the results suggest that these two molecules are potential candidates for further development as antitubercular agents.

摘要

鉴于基于植物提取物的抗结核药物研究存在的缺点,以及缺乏具有抗结核活性的氟化天然产物,促使我们努力合成并表征一系列新型的十五种取代氟苯并咪唑。新合成的化合物通过红外光谱、氢核磁共振、碳核磁共振、质谱和元素分析进行表征。通过MABA方法评估了合成的化合物4(a - f)和5(b - j)对H37Rv菌株(ATCC 27294)的抗分枝杆菌活性。在苯并咪唑环的2位和6位引入亚甲二氧基苯基部分,得到了具有与已报道具有抗结核活性的天然化合物相当或更强抗结核活性的化合物4d和5i。在这十五种测试化合物中,4d和5i表现为有前景的活性物质,其最低抑菌浓度低于芝麻素对致病性H37Rv菌株的最低抑菌浓度。抗结核活性结果表明这些化合物可能适合进一步的先导优化。通过MTT法评估了这些活性化合物对THP - 1细胞系的细胞毒性作用,结果表明这两种分子是作为抗结核药物进一步开发的潜在候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac73/5610749/c372f33f354d/ijpr-16-0929-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验